BellRing Brands, Inc. logo

BellRing Brands, Inc.

BRBR

NYSEConsumer DefensivePackaged Foods

Previous close

$10.19

−$0.26 · -2.49%

Aug 21, 4:00 PM ET

BRBR company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

80

Undervalued

Momentum

40

Weakening

Sentiment

71

Bullish

Risk resilience

41

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

BellRing Brands Inc., along with its various subsidiaries, is a provider of diverse nutritional products, serving both the United States and international markets. The company's main offerings are protein-fortified ready-to-drink shakes and powdered protein supplements, which are primarily marketed under its well-known Premier Protein and Dymatize labels. These items are made accessible to consumers through a wide range of distribution points, including warehouse clubs, grocery stores, pharmacies, large retail chains, online stores, specialized health shops, and convenience outlets. BellRing Brands Inc. commenced operations in 2019 and has its corporate headquarters located in Saint Louis, Missouri.

Industry
Packaged Foods
Sector
Consumer Defensive
Headquarters
US
CEO
Mike Axelrod
Listed since
Oct 18, 2019
Employees
530

Market position

Day range

Current $10.19

52-week range

Current $10.19

Open
$10.41
Previous close
$10.45
Volume
1.57M
0.31× average
Average volume
5.08M
Average daily volume
Market cap
1.18B USD
Beta
0.52
Market reference 1
50-day average
$11.7488
-13.27% below average
200-day average
$18.1047
-43.72% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
5.64B USD
EV / EBITDA
14.99×
Earnings yield
4.69%
Free cash flow yield
5.55%

Profitability & efficiency

Return on equity
-47.63%
Return on assets
22.98%
Return on invested capital
40.46%

Financial health

Current ratio
2.35×

Earnings

EPS beat rate
64%
7 beats, 3 misses, 1 met estimate
Average EPS surprise
+4.15%
11 comparable reports
Latest EPS result
0.3
Estimate 0.37 · Miss by 18.66%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.620.450.290.12Q1 '25BeatQ2 '25MetQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 3, 2025: actual 0.58, estimate 0.47, surprise +23.40%, Beat. Q2 2025, reported May 5, 2025: actual 0.53, estimate 0.53, surprise 0.00%, Met estimate. Q3 2025, reported Aug 4, 2025: actual 0.55, estimate 0.49, surprise +12.24%, Beat. Q4 2025, reported Nov 18, 2025: actual 0.51, estimate 0.546, surprise -6.59%, Miss. Q1 2026, reported Feb 3, 2026: actual 0.37, estimate 0.31, surprise +19.35%, Beat. Q2 2026, reported May 5, 2026: actual 0.14, estimate 0.31, surprise -54.84%, Miss. Q3 2026, reported Aug 4, 2026: actual 0.3, estimate 0.369, surprise -18.66%, Miss. Q4 2026, reported Nov 17, 2026: actual —, estimate 0.21, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates678.07M611.49M544.91M478.33MQ1 '25MissQ2 '25BeatQ3 '25MissQ4 '25BeatQ1 '26BeatQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 3, 2025: actual 532.9M USD, estimate 577.56M USD, surprise -7.73%, Miss. Q2 2025, reported May 5, 2025: actual 588M USD, estimate 578.69M USD, surprise +1.61%, Beat. Q3 2025, reported Aug 4, 2025: actual 547.5M USD, estimate 633.84M USD, surprise -13.62%, Miss. Q4 2025, reported Nov 18, 2025: actual 648.2M USD, estimate 633.84M USD, surprise +2.27%, Beat. Q1 2026, reported Feb 3, 2026: actual 537.3M USD, estimate 504.41M USD, surprise +6.52%, Beat. Q2 2026, reported May 5, 2026: actual 598.7M USD, estimate 608.88M USD, surprise -1.67%, Miss. Q3 2026, reported Aug 4, 2026: actual 570.4M USD, estimate 548.72M USD, surprise +3.95%, Beat. Q4 2026, reported Nov 17, 2026: actual —, estimate 651.99M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$13.20

29.54% upside
Past 12 months12-month forecastHigh $15.00Average $13.20Low $11.00

Recent analyst actions

12 institutions

BRBR peers

ETFs holding BRBR

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research BRBR

research.disclaimer